1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

10 Nov 2025
Admin
News Article

SciBase Expands Collaboration with Castle Biosciences and Secures SEK 20 Million Loan

SciBase Holding AB (SciBase), a developer of AI-based diagnostic solutions for skin disorders, announced an expanded collaboration and license agreement with Castle Biosciences (Castle), alongside a new SEK 20 million loan agreement between the two companies.

The original partnership, initiated in June 2025, focuses on developing diagnostic tools for skin barrier health and atopic dermatitis (AD). Under the expanded terms, Castle will gain increased autonomy over the manufacturing process, while SciBase will benefit from additional funding to support production scale-up and market growth.

Funding and Loan Details

Loan Amount: SEK 20 million
Term: Five years
Interest Rate: STIBOR + 2% per annum, payable quarterly starting March 31, 2026
Repayment: In cash or through conversion to SciBase shares, based on the 30-day volume-weighted average price prior to repayment
Security: Loan secured by a share pledge over SciBase AB shares

Strategic Focus

The first joint clinical study aims to develop a test that predicts flare-ups in patients with atopic dermatitis, with potential to expand into additional dermatological indications.

“Our collaboration with Castle Biosciences is moving ahead at full speed,” said Pia Renaudin, CEO of SciBase. “This loan secures the resources to ramp up production, strengthen margins, and accelerate the global adoption of Nevisense across skin barrier health and skin cancer diagnostics.”

About the Companies

Castle Biosciences is a US-based diagnostics company focused on improving patient outcomes through innovative, data-driven tests that guide clinical decisions.

SciBase is a global medical technology company developing Nevisense, an AI-powered point-of-care platform combining electrical impedance spectroscopy (EIS) and advanced analytics for the early detection and prevention of skin diseases.

This information was disclosed in accordance with the EU Market Abuse Regulation.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!